Funding - February 12, 2016
Biosergen receives innovation grant
The Norwegian biotech company Biosergen AS, developing new drugs based on the approach ‘engineered biosynthesis’, has received the BIA innovation award from the Research Council of Norway. 181 companies submitted applications for BIA funding and Biosergen AS belongs to the 50 awarded ones. Based on their expertise in biosynthetic engineering, Biosergen AS is currently running a development program for […]
Funding - January 26, 2016
AstraZeneca establish translational research fund
AstraZeneca together with GlaxoSmithKline and Johnson & Johnson has partnered with three universities, Imperial College London, the University of Cambridge and University College London (UCL), to create the Apollo Therapeutics Fund. This new consortium aims to convert outstanding academic science from the three universities into innovative medicines for a broad range of diseases. The fund […]
Funding - January 4, 2016
Kavli Institute given multimillion grant
Pauline Braathen has given the Kavli Institute for Systems Neuroscience US $5 million to establish a new center at the Norwegian University of Science and Technology (NTNU) in Trondheim. The Kavli Foundation has matched this donation with NOK 50 million. British-born Pauline Braathen announced in September that she would donate US $5 million to establish […]
Funding - July 3, 2015
Norway Invests in Biomedical Research
The Norwegian Research Council recently announced four large investments in biomedical research for a total of 255 MNOK. Out of the total, 60 MNOK will go to to sequencing and precision medicine, 80 MNOK to national biobanks, 65 MNOK to brain research and 50 MNOK to Norwegian Clinical Research Infrastructure Network. “This is great news. […]
Funding - March 25, 2015
Janssen Joins Dementia Project
Johnson & Johnson’s Janssen Pharmaceutical Companies plan to invest $10 million in a new UK government-led global dementia discovery fund for research to find ways to prevent and treat dementia and Alzheimer’s disease. The investment will come through its affiliate venture arm, Johnson & Johnson Innovation – JJDC, Inc. The global Dementia Discovery Fund brings […]
Funding - February 23, 2015
Norwegian Research Council Issues Grants
The Norwegian Research Council granted BerGenBio, Lifandis and Smartfish funding through the Program for User-Driven Research Based Innovation (BIA). The Research Council will grant a record amount of more than 600 MNOK to 65 Norwegian companies, of which nine are biotech companies. BerGenBio, Lifandis and Smartfish will receive about 10 million NOK each over four […]
